-
-
-
-
-
-
-
Optimi Health Launches Standardized Microdose Psilocybin Products for Clinical Research
-
-
-
-
-
-
-
Optimi Health secures ibogaine supply for drug development
-
-
-
-
-
-
-
Optimi Health Welcomes Expanded Psychedelic-Assisted Therapy Access Under Updated Authorized Prescriber Framework in Australia
-
-
-
-
-
-
-
Optimi Health Announces Pricing of Oversubscribed US$15 Million Public Offering and Nasdaq Uplisting
-
-
15,652 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

